Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

IB-367: preclinical results presented at ICAAC support clinical trials in oral mucositis

Sep. 30, 1998

Celgene initiates development of Thalomid for hematological cancers

Sep. 30, 1998

Pharmacyclics starts phase III Gd-Tex trial for brain metastases

Sep. 28, 1998

Polish researchers present new antitumor agents

Sep. 28, 1998

Investigators at C&C Research design new antiestrogenic agents

Sep. 28, 1998

HMR grants Matrix rights to anticancer agent about to enter phase II

Sep. 25, 1998

Oxigene updates Neu-Sensamide development status

Sep. 25, 1998

Biomira and Biovector collaborate on development of idiotypic B-cell lymphoma vaccine

Sep. 24, 1998

New paclitaxel formulation enters clinical trials

Sep. 24, 1998

Another series of DC-107 derivatives from Kyowa Hakko particularly useful as antitumor agents

Sep. 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...